A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
RemeGen Co., Ltd.
RemeGen Co., Ltd.
TaiHao Medical Inc.
Maastricht University Medical Center
IRCCS San Raffaele
Centro di Riferimento Oncologico - Aviano
Sun Yat-sen University
KK Women's and Children's Hospital
ChineseAMS
Fuzhou General Hospital
Zhejiang Cancer Hospital
Peking Union Medical College Hospital
Zhejiang Cancer Hospital
King's College London
Shandong Cancer Hospital and Institute
University of British Columbia
Medifocus, Inc.
Women's College Hospital